Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 30;2(2):52-54.
doi: 10.1016/j.jimed.2019.07.002. eCollection 2019 May.

Whole-course management of interventional treatment in liver cancer patients with portal hypertension

Zhenkang Qiu  1 , Gui Song Wang  1 , Fei Gao  1
Affiliations

Whole-course management of interventional treatment in liver cancer patients with portal hypertension

Zhenkang Qiu et al. J Interv Med. .

Erratum in

Abstract

Primary liver cancer often occurs in patients with hepatitis and cirrhosis. Some patients have portal hypertension due to cirrhosis, and present with varying degrees of collateral circulation, splenomegaly and hypersplenism, ascites, and liver dysfunction. It often interferes with the treatment of tumors and affects the disease prognosis. There are internationally recognized guidelines for interventional treatment of liver cancer and portal hypertension which will not be repeated in this paper. This paper focuses on how to treat portal hypertension and intervene with tumors in the treatment of liver cancer to optimize the management of patients with liver cancer and portal hypertension. We propose that the Interventional Management Mode of Liver Cancer with Portal Hypertension can improve the treatment of liver cancer patients with portal hypertension.

Keywords: Liver cancer; Portal hypertension; TIPS.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Interventional management mode of liver cancer with portal hypertension.
See this image and copyright information in PMC

References

    1. Berzigotti A., Reig M., Abraldes J.G. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis:a systematic review and meta-analysis. Hepatology. 2015;61:526–536. - PubMed
    1. Huang J.H., Gao F., Gu Y.K. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization. World J Gastroenterol. 2007;13 6593-6397. - PMC - PubMed
    1. Boyer T.D., Haskal Z.J., American Association for the Study of Liver Diseases The role of transjugular intrahepatic portosystemic shunt (TIPS)in the management of portal hypertension: update 2009. Hepatology. 2010;51:306. - PubMed
    1. de Franchis R. Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752. - PubMed
    1. BruixJ Reig M., Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150:835–853. - PubMed

LinkOut - more resources